Board of Trustees

The Research Institute is governed by the Board of Trustees (BOT). The BOT shall consist of 6 elected trustees from the ACCP membership and between 3 and 6 appointed trustees and four Ex-Officio Members. The BOT is responsible for, but not limited to, accomplishing the following:

  • Develop strategic plans and policies to conduct business and for future growth;
  • Identify, prioritize, and implement research and education agendas and programs for the corporation; and
  • Guide and actively participate in the fund raising efforts of the Corporation.

For a list of Chairs and Board Members on the Board of Trustees since 1985, click here.


Susan C. Fagan, Pharm.D., FCCP, BCPS Chair
Susan C. Fagan, Pharm.D., FCCP, BCPS
Stuart T. Haines, Pharm.D., FCCP, BCPS Vice-Chair
Stuart T. Haines, Pharm.D., FCCP, BCPS
Jacqueline S. Marinac, PharmD, BCPS Secretary, Ex-Officio
ACCP Research Institute, Director, Research

Jacqueline S. Marinac, PharmD, BCPS
Mark A. Munger, Pharm.D., FCCP Treasurer
Mark A. Munger, Pharm.D., FCCP
Michael S. Maddux, Pharm.D., FCCP Ex-Officio Trustee
ACCP Executive Director

Michael S. Maddux, Pharm.D., FCCP
John D. Cleary, Pharm.D., FCCP, BCPS Elected Trustee
John D. Cleary, Pharm.D., FCCP, BCPS
Thomas C. Dowling, Pharm.D., Ph.D. Elected Trustee
Thomas C. Dowling, Pharm.D., Ph.D.
Howard McLeod, Pharm.D., FCCP Elected Trustee
Howard McLeod, Pharm.D., FCCP
Gary C. Yee, Pharm.D., FCCP, BCOP Elected Trustee
Gary C. Yee, Pharm.D., FCCP, BCOP
James Caro, R.Ph., MBA Appointed Trustee
James Caro, R.Ph., MBA
  Appointed Trustee
Richard F. de Leon, Pharm.D.
Mary Anne Koda-Kimble, Pharm.D. Appointed Trustee
Mary Anne Koda-Kimble, Pharm.D.